TOXYLACT: a03cb summary
The first professional lActological database in the word
Pharmacological class and composition
ATC
A03CB belongs to the group “spasmolytics in
combination with psycholeptics” within drugs for
functional gastrointestinal disorders.medpedia.framar
The subgroup comprises belladonna alkaloids and
related synthetic tropane derivatives (e.g.
methylscopolamine, belladonna total alkaloids,
atropine, methylhomatropine, hyoscyamine) combined
with psycholeptic agents such as sedatives,
anxiolytics or antipsychotics.medpedia.framar
Psycholeptics
exert a calming effect on the central nervous system
and are widely used in medicine, including in
fixed-dose combinations with other drugs.medpedia.framar
Belladonna itself contains tropane alkaloids, notably
atropine in the leaves and other related alkaloids in
the roots, which account for its potent
anticholinergic activity.medpedia.framar
Mechanism of action and clinical use
Belladonna
alkaloids and their derivatives act as competitive
antagonists at muscarinic acetylcholine receptors,
reducing parasympathetic tone and thereby decreasing
gastrointestinal smooth muscle spasm and secretions.medpedia.framar
The psycholeptic component modulates central
neurotransmission (e.g. GABAergic or dopaminergic
pathways), providing anxiolytic or sedative effects
that may alleviate visceral hypersensitivity,
anxiety-related symptom perception and associated
functional complaints.medpedia.framar
Clinically,
A03CB combinations are used in the management of
functional gastrointestinal disorders characterized by
spasm and pain, such as irritable bowel syndrome or
biliary colic, where both smooth muscle relaxation and
central sedation are desired.medpedia.framar
Traditional uses of belladonna preparations also
include treatment of hepatic and gallbladder
disorders, cardiac arrhythmias and other conditions,
but such uses are outside contemporary evidence-based
indications and carry notable toxicity risks.medpedia.framar
Toxicological profile
The
therapeutic dose of belladonna alkaloids lies close to
the toxic dose, and overdose or accumulation can
easily occur, especially in vulnerable populations and
in combination therapy.medpedia.framar
Anticholinergic toxicity presents with peripheral and
central manifestations including mydriasis, loss of
voice, tremor of the extremities, dry mucous
membranes, tachycardia, urinary retention, confusion
and, in severe cases, hallucinations or coma.medpedia.framar
The
plant’s root is considered the most poisonous part due
to higher alkaloid content, and inappropriate use of
crude herbal material further increases the risk of
severe poisoning.medpedia.framar
In fixed A03CB products, toxicity risk is compounded
by co-administered psycholeptics, which can add
sedation, respiratory depression, cognitive impairment
and interaction potential with other central nervous
system depressants.medpedia.framar
Lactation safety considerations
From
a lactological perspective, belladonna alkaloids and
related anticholinergics may pass into breast milk to
varying degrees, potentially causing anticholinergic
effects (e.g. irritability, poor feeding,
constipation, urinary retention) in the breastfed
infant, especially with repeated dosing or high
maternal exposure.medpedia.framar
The central sedative properties of the psycholeptic
component raise additional concerns: infant
drowsiness, hypotonia, impaired suck and, rarely,
respiratory depression are plausible, particularly in
neonates and preterm infants with immature drug
clearance.medpedia.framar
Given
the narrow therapeutic index of belladonna derivatives
and the difficulty in predicting individual infant
exposure, A03CB combinations should generally be
avoided during breastfeeding when safer alternatives
for functional gastrointestinal disorders are
available.medpedia.framar
If, exceptionally, such a combination is deemed
necessary, use of the lowest effective maternal dose
for the shortest possible duration, careful selection
of agents with better-known lactation profiles, and
close monitoring of the infant for anticholinergic or
sedative effects are advisable.medpedia.framar
Formulations, special uses and practical notes
Belladonna-containing
medicinal products exist in multiple pharmaceutical
forms, including ointments, extracts, tinctures and
suppositories, as well as homeopathic preparations,
although the latter typically contain highly diluted
amounts.medpedia.framar
Homeopathic uses have been described for inflammatory
conditions of the respiratory system, meninges,
urogenital tract, skin and joints, but these
indications do not alter the underlying toxicological
profile of concentrated belladonna alkaloid
preparations.medpedia.framar
In
all settings, the combination with psycholeptics
requires attention to cumulative sedative burden,
concomitant CNS depressants, and patient-specific
factors such as age, comorbidities and polypharmacy.medpedia.framar
Healthcare professionals should counsel patients that
self-medication with belladonna-containing products,
especially non-standardized herbal preparations, may
result in serious anticholinergic poisoning and is
contraindicated in breastfeeding without specialist
evaluation.medpedia.framar



